SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-018309
Filing Date
2024-06-27
Accepted
2024-06-27 16:03:29
Documents
2
Period of Report
2024-06-27

Document Format Files

Seq Description Document Type Size
1 form3-06272024_080626.html 3  
1 form3-06272024_080626.xml 3 12702
2 ex24-06272024_080628.htm EX-24 4370
  Complete submission text file 0001415889-24-018309.txt   18700
Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 650-231-6625
ALUMIS INC. (Issuer) CIK: 0001847367 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ALUMIS INC. 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Bradley Mark Christopher (Reporting) CIK: 0002023657 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42143 | Film No.: 241078990